z-logo
open-access-imgOpen Access
In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?
Author(s) -
Bonnie Yuan Tone Cheung
Publication year - 2022
Publication title -
veterinary evidence
Language(s) - English
Resource type - Journals
ISSN - 2396-9776
DOI - 10.18849/ve.v7i2.569
Subject(s) - medicine , atopic dermatitis , visual analogue scale , disease , clinical trial , physical therapy , randomized controlled trial , dermatology life quality index , dermatology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom